Surgery Partners, Inc. filed a DEFA14A with the SEC on November 16, 2026, disclosing that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc., has commenced a consent solicitation from holders of $1,225,000,000 in aggregate principal amount of 7.250% Senior Notes due 2032 in connection with the company's pending merger with Spyglass Topco, LLC.

Key Highlights

  • Notes outstanding: Surgery Center Holdings, Inc. is soliciting consents from holders of $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos. 86881W AF9 / U86786 AD9 / U86786 AE7).
  • Consent fee: Holders who validly deliver and do not revoke consents before the expiration time are eligible to receive $2.50 per $1,000 in principal amount of Notes.
  • Record date and expiration: Only holders of record as of 5:00 p.m. New York City time on November 20, 2026 are eligible, and the solicitation is scheduled to expire at that same time on November 20, 2026.
  • Requisite consents threshold: The proposed amendments require consent of holders of a majority of the aggregate principal amount of the Notes outstanding.
  • Merger agreement: Surgery Partners entered into an Agreement and Plan of Merger with Spyglass Topco, LLC on October 23, 2026, as amended by Amendment No. 1 on November 8, 2026.
  • Expected merger closing: According to the filing, the merger "is expected to close in the first quarter of 2027, subject to the approval of Surgery Partners' stockholders, required regulatory approvals and other customary closing conditions."
  • Solicitation agent: Jefferies LLC is serving as solicitation agent, and S&P Global Inc. is serving as information and tabulation agent.

Indenture Amendments Tied to Pending Merger with Bon Secours Mercy Health Affiliate

Surgery Partners, described in the filing as a healthcare services company with an outpatient delivery model focused on surgical and related ancillary care, disclosed through a press release filed as soliciting material under Rule 14a-12 that its subsidiary Surgery Center Holdings, Inc. launched the consent solicitation on November 16, 2026. The consent solicitation is governed by a Consent Solicitation Statement of the same date and is being made pursuant to the indenture originally dated April 10, 2024, with Wilmington Trust, National Association, as trustee. The company trades on Nasdaq under the symbol SGRY (NASDAQ:SGRY).

According to the filing, the purpose of the proposed amendments is to designate Bon Secours Mercy Health, Inc. ("BSMH"), HealthSpan Partners (a 501(c)(3) Ohio corporation affiliated with BSMH), their respective affiliates, and certain groups of which any of them are members, as "Permitted Holders" under the indenture, in addition to the existing Permitted Holders. The filing states that if the proposed amendments are not consented to and operative, the consummation of the merger would constitute a "Change of Control" under the indenture, which would require the issuer to make an offer to purchase all outstanding Notes at 101% of principal amount plus accrued and unpaid interest.

The filing clarifies that the proposed amendments, if operative, "will not alter the Issuer's obligation to pay the principal of or interest on the Notes or the stated interest rate or maturity date of the Notes." The supplemental indenture setting out the proposed amendments will become effective upon execution but will only become operative immediately prior to the consummation of the merger, provided the consent fee has been paid. If the merger is not consummated on or prior to five business days after the End Date as defined in the merger agreement, the proposed amendments will not become operative, though holders that received the consent fee will retain it. The filing also notes that the proposed amendments becoming operative is not a condition to the consummation of the merger.

What Was Disclosed

Surgery Partners filed soliciting material disclosing its subsidiary's consent solicitation on $1,225,000,000 of 7.250% Senior Notes due 2032. The solicitation seeks indenture amendments to prevent an automatic Change of Control designation upon completion of the pending merger with Spyglass Topco, LLC, expected to close in the first quarter of 2027.